BackProvention Bio Overview

Provention Bio Other Current Assets

Track Provention Bio's other current assets ($7.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$7.06M
17.89% YoYΔ $1.07M vs prior year quarter

Peer average

Loading

Provention Bio Other Current Assets History

Loading

Provention Bio vs. peers: Other Current Assets Comparison

Loading

Provention Bio Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Provention Bio (PRVB) FAQ

As of the most recent data (December 2022), PRVB shows a other current assets of $7.1M. That compares with $6M in the prior-year period — up 17.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PRVB's other current assets is now $7.1M (was $6M) — a 17.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Provention Bio is outperforming or lagging.

Tracking PRVB's other current assets over time shows whether Provention Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $7.1M That compares with $6M in the prior-year period — up 17.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Provention Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $7.1M) with ownership activity and broader fundamentals.

Provention Bio's other current assets is $7.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.